cGxP.wire https://validator.w3.org/feed/docs/rss2.html FDA Approves Tregzi for Chronic GVHD Prevention in Blood Cancer Mesoblast Receives FDA BLA Filing Number for Rexlemestrocel-L Oxford-Harrington and Oxford Launch £5.25M Pediatric Oncology Program AlzeCure, QuantumCell Partner to Advance NeuroRestore ACD856 Can-Fite Reports Positive Phase 2a Namodenoson Safety Datar Santhera Reports Positive Phase 1 AGAMREE Data InnoCare Doses First Patient in ICP-B208 ADC Clinical Trial Median Technologies Expands AI Lung Cancer Screening in Europe Ascletis Submits FDA INDs for Next-Generation Obesity Drugs IntelliGenome Wins INVIMA Approval for CRISPR-TB Test FDA Approves Casgevy for Young Children With Sickle Cell Disease NewAmsterdam Pharma to Present Obicetrapib Alzheimer’s Data Visby Medical Receives FDA Clearance for First Multi-Virus Home PCR Evaxion to Present EVX-V1 CMV Vaccine Preclinical Data Artelo Biosciences Reports Positive ART26.12 Pain Data Sana Biotechnology to Present UP421 Clinical Data at EASD 2026 Oryzon Raises €12M to Accelerate Clinical Development Polyrizon Advances NASARIX™ Toward First-in-Human Trial Ribo, Madrigal Advance siRNA Therapy for MASH Treatment Allarity Therapeutics Secures U.S. Patent for DRP® Platform CraniUS Therapeutics Wins NIH Award for NeuroPASS Platform Xeltis Surpasses 50% Enrollment in aXess US Trial M&M International Acquires KC Tech to Expand MedTech Portfolio Nuvaira Develops First Targeted Therapy for COPD Phenotype FDA Approves Tregzi to Prevent Chronic GVHD in Blood Cancer AdJane Validates OMV Vaccine Platform in Human Phase I Trial Immunomic Therapeutics Doses First Patient in ITI-9001 Trial United Therapeutics Expands Cell Therapy with Thymmune Deal Sanyou Bio Partners Baiyunshan Xihe for Radiopharma Innovation Circular Genomics Launches CircPATH for Early Alzheimer’s Skyhawk Reports 12-Month Phase 1/2 Results for SKY-0515 Nona, Lonza Partner on BBB Technology for CNS Therapies Trilogy Laboratories Acquires YNS Cosmeceuticals SkinSpirit Launches PDRN Salmon DNA Regenerative Treatment Cannabix Detects Methamphetamine in Human Breath Treos Bio Reports PolyPEPI1018 Immune Remodeling Data CSPC Pharma Secures Up to $1.77B AstraZeneca siRNA Deal BridgeBio Reports Kidney Benefits With Attruby in ATTR-CM Arcturus Therapeutics Partners With Thermo Fisher for ARCT-032 PolarityBio Submits FDA BLA for SkinTE in Diabetic Foot Ulcers AAOS Issues First Clinical Guideline for Ankle Osteoarthritis Tenax Therapeutics to Present LEVEL Phase 3 Data at ESC VERAXA Partners with ATUM for BiTAC-TCE Development Brii Bio Advances HBV Functional Cure With Phase 2b Results Newron Reports FDA Progress on Evenamide Phase 3 ENIGMA-TRS 2 Trial NKGen Biotech to Highlight Troculeucel Alzheimer’s Program at BIOCHINA Forum Revolution Medicines Reports Promising Phase 1/2 Zoldonrasib Combination Data in Metastatic Pancreatic Cancer Multitude Therapeutics Reports Positive AMT-676 Phase I Data Myriad Genetics Prolaris Study Validates Prostate Risk Test Endologix Reports 3-Year DETOUR2 Trial Success in PAD